Listing of Newsroom articles
Press Releases
HHS Releases Final Guidance for Second Cycle of Historic Medicare Drug Price Negotiation Program
Final guidance builds on success of the first cycle of drug price negotiations and details how HHS will help ensure negotiated prices reach people with Medicare in 2026 and 2027 Read more about HHS Releases Final Guidance for Second Cycle of Historic Medicare Drug Price Negotiation Program
News Alert
CMS to Provide Hurricane Helene Public Health Emergency Accelerated and Advance Payments to Medicare Fee-for-Services Providers and Suppliers
CMS to Provide Hurricane Helene Public Health Emergency Accelerated and Advance Payments to Medicare Fee-for-Services Providers and Suppliers October 2, 2024 The U.S. Department of Health and Human Services (HHS) through the Centers for Medicare & Medicaid Services (CMS) is taking action to support Read more about CMS to Provide Hurricane Helene Public Health Emergency Accelerated and Advance Payments to Medicare Fee-for-Services Providers and Suppliers
Fact Sheets
Fact Sheet: Report on the Study of the Acute Hospital Care at Home Initiative
On September 30, 2024, the Centers for Medicare & Medicaid Services (CMS) released a report on the agency’s study of the Acute Hospital Care at Home (AHCAH) initiative, which allows certain Medicare-certified hospitals to treat patients with inpatient-level care at home. While the initiative was Read more about Fact Sheet: Report on the Study of the Acute Hospital Care at Home Initiative
Press Releases
HHS Announces Cost Savings for 54 Prescription Drugs Thanks to the Medicare Inflation Rebate Program Established by the Biden-Harris Administration’s Lower Cost Prescription Drug Law
Under President Biden’s and Vice President Harris’s Inflation Reduction Act, some people with Medicare will pay less for some Part B drugs because the drug’s price increased faster than the rate of inflation. Read more about HHS Announces Cost Savings for 54 Prescription Drugs Thanks to the Medicare Inflation Rebate Program Established by the Biden-Harris Administration’s Lower Cost Prescription Drug Law
Press Releases
Medicare Advantage and Medicare Prescription Drug Programs to Remain Stable as CMS Implements Improvements to the Programs in 2025
Today, the Centers for Medicare & Medicaid Services (CMS) announced that average premiums, benefits, and plan choices for Medicare Advantage (MA) and the Medicare Part D prescription drug program will remain stable in 2025. Average premiums are projected to decline in both the MA and Part D programs Read more about Medicare Advantage and Medicare Prescription Drug Programs to Remain Stable as CMS Implements Improvements to the Programs in 2025
Fact Sheets